Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Andriulli

Showing results (51-60 of 208) with videos related to

Pageof 21
Sort By:
Minerva Gastroenterologica E Dietologica|September 1, 1994
[Osteoarticular manifestations during liver and gastrointestinal diseases]F Perri, M Pastore, V Annese, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2003
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'F Perri, V Festa, A Merla, et al.
Journal of Clinical Gastroenterology|June 1, 1984
Relation between serum cathodic trypsinogen levels and exocrine pancreatic functionA Andriulli, G Masoero, V Benitti, et al.
Endoscopy|January 26, 2012
Endoscopic removal of gallstone impacted in the rectumF Perri, F Terracciano, M Gentile, et al.
American Journal of Diseases of Children (1960)|February 1, 1983
Serum trypsinlike immunoreactivity in cystic fibrosis. An aid in assessing progressive involvement of the pancreasG Masoero, A Andriulli, B Santini, et al.
Digestion|January 1, 1983
Dose-related effect of bombesin on serum cationic trypsinogen levelsA Andriulli, A Amato, C Valente, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2003
Dyspepsia and Helicobacter pylori infection: a prospective multicentre observational studyF Perri, V Festa, E Grossi, et al.
Clinical Nephrology|May 1, 1985
Patients with chronic renal failure are not at a risk of developing chronic peptic ulcersA Andriulli, B Malfi, S Recchia, et al.
Gastroenterology|July 1, 1979
Amylase to creatine clearance ratio in renal diseasesA Andriulli, R Bergia, G Masoero, et al.
Digestion|January 1, 1989
Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapyA Andriulli, A Arrigoni, T Gindro, et al.
Pageof 21

Showing results (51-60 of 208) with videos related to

Sort By:
Pageof 21
Minerva Gastroenterologica E Dietologica|September 1, 1994
[Osteoarticular manifestations during liver and gastrointestinal diseases]F Perri, M Pastore, V Annese, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2003
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'F Perri, V Festa, A Merla, et al.
Journal of Clinical Gastroenterology|June 1, 1984
Relation between serum cathodic trypsinogen levels and exocrine pancreatic functionA Andriulli, G Masoero, V Benitti, et al.
Endoscopy|January 26, 2012
Endoscopic removal of gallstone impacted in the rectumF Perri, F Terracciano, M Gentile, et al.
American Journal of Diseases of Children (1960)|February 1, 1983
Serum trypsinlike immunoreactivity in cystic fibrosis. An aid in assessing progressive involvement of the pancreasG Masoero, A Andriulli, B Santini, et al.
Digestion|January 1, 1983
Dose-related effect of bombesin on serum cationic trypsinogen levelsA Andriulli, A Amato, C Valente, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2003
Dyspepsia and Helicobacter pylori infection: a prospective multicentre observational studyF Perri, V Festa, E Grossi, et al.
Clinical Nephrology|May 1, 1985
Patients with chronic renal failure are not at a risk of developing chronic peptic ulcersA Andriulli, B Malfi, S Recchia, et al.
Gastroenterology|July 1, 1979
Amylase to creatine clearance ratio in renal diseasesA Andriulli, R Bergia, G Masoero, et al.
Digestion|January 1, 1989
Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapyA Andriulli, A Arrigoni, T Gindro, et al.
Pageof 21